Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 1543322
[patent_doc_number] => 06372793
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-16
[patent_title] => 'Method for treatment of a neurological disease characterized by impaired neuromodulator function'
[patent_app_type] => B1
[patent_app_number] => 09/642576
[patent_app_country] => US
[patent_app_date] => 2000-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 11016
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/372/06372793.pdf
[firstpage_image] =>[orig_patent_app_number] => 09642576
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/642576 | Method for treatment of a neurological disease characterized by impaired neuromodulator function | Aug 18, 2000 | Issued |
Array
(
[id] => 1536415
[patent_doc_number] => 06337328
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-08
[patent_title] => 'Bupropion metabolites and methods of use'
[patent_app_type] => B1
[patent_app_number] => 09/640725
[patent_app_country] => US
[patent_app_date] => 2000-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18119
[patent_no_of_claims] => 94
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/337/06337328.pdf
[firstpage_image] =>[orig_patent_app_number] => 09640725
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/640725 | Bupropion metabolites and methods of use | Aug 17, 2000 | Issued |
Array
(
[id] => 1521240
[patent_doc_number] => 06413999
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-02
[patent_title] => 'Treatment for acute physical insult to the central nervous system'
[patent_app_type] => B1
[patent_app_number] => 09/640020
[patent_app_country] => US
[patent_app_date] => 2000-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5979
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/413/06413999.pdf
[firstpage_image] =>[orig_patent_app_number] => 09640020
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/640020 | Treatment for acute physical insult to the central nervous system | Aug 16, 2000 | Issued |
Array
(
[id] => 1298071
[patent_doc_number] => 06627625
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-30
[patent_title] => 'Treatment of behavioral disorders with -lactam compounds'
[patent_app_type] => B1
[patent_app_number] => 09/640363
[patent_app_country] => US
[patent_app_date] => 2000-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 70
[patent_no_of_words] => 27498
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/627/06627625.pdf
[firstpage_image] =>[orig_patent_app_number] => 09640363
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/640363 | Treatment of behavioral disorders with -lactam compounds | Aug 15, 2000 | Issued |
09/639291 | Drug treatment for restless leg syndrome | Aug 14, 2000 | Abandoned |
Array
(
[id] => 1561488
[patent_doc_number] => 06362173
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-26
[patent_title] => 'Methods for treating psychosis associated with cocaine addiction with glucocorticoid receptor antagonists'
[patent_app_type] => B1
[patent_app_number] => 09/639377
[patent_app_country] => US
[patent_app_date] => 2000-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13262
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/362/06362173.pdf
[firstpage_image] =>[orig_patent_app_number] => 09639377
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/639377 | Methods for treating psychosis associated with cocaine addiction with glucocorticoid receptor antagonists | Aug 14, 2000 | Issued |
Array
(
[id] => 1419737
[patent_doc_number] => 06514949
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-04
[patent_title] => 'Method compositions for treating the inflammatory response'
[patent_app_type] => B1
[patent_app_number] => 09/634407
[patent_app_country] => US
[patent_app_date] => 2000-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 13
[patent_no_of_words] => 9122
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/514/06514949.pdf
[firstpage_image] =>[orig_patent_app_number] => 09634407
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/634407 | Method compositions for treating the inflammatory response | Aug 8, 2000 | Issued |
Array
(
[id] => 4273461
[patent_doc_number] => 06323239
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-27
[patent_title] => 'Treatment of addiction to ethanol and addictive-related behavior'
[patent_app_type] => 1
[patent_app_number] => 9/635578
[patent_app_country] => US
[patent_app_date] => 2000-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 20465
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/323/06323239.pdf
[firstpage_image] =>[orig_patent_app_number] => 635578
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/635578 | Treatment of addiction to ethanol and addictive-related behavior | Aug 8, 2000 | Issued |
Array
(
[id] => 4305540
[patent_doc_number] => 06326385
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-04
[patent_title] => 'Methods for treating or preventing pain'
[patent_app_type] => 1
[patent_app_number] => 9/631747
[patent_app_country] => US
[patent_app_date] => 2000-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 7
[patent_no_of_words] => 13712
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/326/06326385.pdf
[firstpage_image] =>[orig_patent_app_number] => 631747
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/631747 | Methods for treating or preventing pain | Aug 3, 2000 | Issued |
Array
(
[id] => 1416706
[patent_doc_number] => 06521639
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-18
[patent_title] => 'Percutaneously applicable preparation and suppository containing an antidementia medicament'
[patent_app_type] => B1
[patent_app_number] => 09/628006
[patent_app_country] => US
[patent_app_date] => 2000-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2976
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/521/06521639.pdf
[firstpage_image] =>[orig_patent_app_number] => 09628006
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/628006 | Percutaneously applicable preparation and suppository containing an antidementia medicament | Jul 27, 2000 | Issued |
Array
(
[id] => 4397416
[patent_doc_number] => 06297280
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-02
[patent_title] => 'Composition and method for suppressing behavior problems of pets'
[patent_app_type] => 1
[patent_app_number] => 9/619713
[patent_app_country] => US
[patent_app_date] => 2000-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6628
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/297/06297280.pdf
[firstpage_image] =>[orig_patent_app_number] => 619713
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/619713 | Composition and method for suppressing behavior problems of pets | Jul 18, 2000 | Issued |
09/616814 | Method of treatment for decreasing mortality resulting from congestive heart failure | Jul 12, 2000 | Abandoned |
09/602790 | Phosphodiesterase type 5 (PDE5) inhibitors for the treatment of selectiveserotonin reuptake inhibitor (SSRI) induced sexual dysfunction | Jun 22, 2000 | Abandoned |
Array
(
[id] => 1504178
[patent_doc_number] => 06465458
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-15
[patent_title] => 'Method of treating or preventing chronic pain with a highly selective norepinephrine reuptake inhibitor'
[patent_app_type] => B1
[patent_app_number] => 09/599213
[patent_app_country] => US
[patent_app_date] => 2000-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9054
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/465/06465458.pdf
[firstpage_image] =>[orig_patent_app_number] => 09599213
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/599213 | Method of treating or preventing chronic pain with a highly selective norepinephrine reuptake inhibitor | Jun 21, 2000 | Issued |
Array
(
[id] => 1566817
[patent_doc_number] => 06376501
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-23
[patent_title] => 'Type 2 helper T cell-selective immune response suppressors'
[patent_app_type] => B1
[patent_app_number] => 09/582176
[patent_app_country] => US
[patent_app_date] => 2000-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13555
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 309
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/376/06376501.pdf
[firstpage_image] =>[orig_patent_app_number] => 09582176
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/582176 | Type 2 helper T cell-selective immune response suppressors | Jun 20, 2000 | Issued |
Array
(
[id] => 1602810
[patent_doc_number] => 06432989
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-13
[patent_title] => 'Use of CRF antagonists to treat circadian rhythm disorders'
[patent_app_type] => B1
[patent_app_number] => 09/587007
[patent_app_country] => US
[patent_app_date] => 2000-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21095
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/432/06432989.pdf
[firstpage_image] =>[orig_patent_app_number] => 09587007
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/587007 | Use of CRF antagonists to treat circadian rhythm disorders | Jun 4, 2000 | Issued |
Array
(
[id] => 4295664
[patent_doc_number] => 06197773
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-06
[patent_title] => 'N-acyl and N-aroyl aralkyl amides as serotonergic agents'
[patent_app_type] => 1
[patent_app_number] => 9/584680
[patent_app_country] => US
[patent_app_date] => 2000-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14256
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/197/06197773.pdf
[firstpage_image] =>[orig_patent_app_number] => 584680
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/584680 | N-acyl and N-aroyl aralkyl amides as serotonergic agents | May 30, 2000 | Issued |
Array
(
[id] => 1478660
[patent_doc_number] => 06451803
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-17
[patent_title] => 'N-acyl and n-aroyl aralkyl amides useful in treating seritonergic disorders'
[patent_app_type] => B1
[patent_app_number] => 09/583691
[patent_app_country] => US
[patent_app_date] => 2000-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13684
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 886
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/451/06451803.pdf
[firstpage_image] =>[orig_patent_app_number] => 09583691
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/583691 | N-acyl and n-aroyl aralkyl amides useful in treating seritonergic disorders | May 30, 2000 | Issued |
Array
(
[id] => 4314851
[patent_doc_number] => 06242465
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-05
[patent_title] => 'Compositions of optically pure (+) norcisapride'
[patent_app_type] => 1
[patent_app_number] => 9/573423
[patent_app_country] => US
[patent_app_date] => 2000-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9009
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/242/06242465.pdf
[firstpage_image] =>[orig_patent_app_number] => 573423
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/573423 | Compositions of optically pure (+) norcisapride | May 17, 2000 | Issued |
Array
(
[id] => 4384003
[patent_doc_number] => 06277887
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-21
[patent_title] => 'Methods for treating Parkinson\'s disease using optically pure (-)-bupropion'
[patent_app_type] => 1
[patent_app_number] => 9/553029
[patent_app_country] => US
[patent_app_date] => 2000-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5018
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/277/06277887.pdf
[firstpage_image] =>[orig_patent_app_number] => 553029
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/553029 | Methods for treating Parkinson's disease using optically pure (-)-bupropion | Apr 19, 2000 | Issued |